Seattle Genetics (SGEN) Holding Has Raised by Platinum Investment Management Ltd; As Clean Harbors (CLH) Market Value Rose, Pivot Point Capital Partners Has Cut Its Position by $10.54 Million

January 17, 2018 - By Henry Gaston

James A. Noonan decreased its stake in Clean Harbors Inc (CLH) by 44.65% based on its latest 2017Q3 regulatory filing with the SEC. Pivot Point Capital Partners Llc sold 188,256 shares as the company’s stock rose 3.54% with the market. The hedge fund run by James A. Noonan held 233,328 shares of the basic industries company at the end of 2017Q3, valued at $13.23M, down from 421,584 at the end of the previous reported quarter. Pivot Point Capital Partners Llc who had been investing in Clean Harbors Inc for a number of months, seems to be less bullish one the $3.19B market cap company. The stock decreased 0.36% or $0.2 during the last trading session, reaching $56. About 218,541 shares traded. Clean Harbors, Inc. (NYSE:CLH) has risen 18.53% since January 17, 2017 and is uptrending. It has outperformed by 1.83% the S&P500.

Kerr Neilson increased its stake in Seattle Genetics Inc (SGEN) by 26.56% based on its latest 2017Q3 regulatory filing with the SEC. Platinum Investment Management Ltd bought 8,500 shares as the company’s stock rose 1.68% with the market. The hedge fund run by Kerr Neilson held 40,500 shares of the health care company at the end of 2017Q3, valued at $2.20M, up from 32,000 at the end of the previous reported quarter. Platinum Investment Management Ltd who had been investing in Seattle Genetics Inc for a number of months, seems to be bullish on the $7.53 billion market cap company. The stock increased 2.73% or $1.39 during the last trading session, reaching $52.34. About 1.36 million shares traded or 44.33% up from the average. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since January 17, 2017 and is uptrending. It has outperformed by 58.98% the S&P500.

Investors sentiment decreased to 1.01 in 2017 Q3. Its down 0.21, from 1.22 in 2017Q2. It turned negative, as 18 investors sold CLH shares while 75 reduced holdings. 32 funds opened positions while 62 raised stakes. 52.13 million shares or 1.97% less from 53.18 million shares in 2017Q2 were reported. Pivot Point Cap Partners Ltd Liability holds 10.54% or 233,328 shares. 19,749 were reported by Hilltop Holdings Incorporated. Ledyard Bancorp has invested 0.01% in Clean Harbors, Inc. (NYSE:CLH). Ubs Asset Mgmt Americas Incorporated has invested 0% in Clean Harbors, Inc. (NYSE:CLH). Bb&T Securities Ltd Liability Corp, Virginia-based fund reported 33,646 shares. Natl Bank Of Montreal Can reported 35,195 shares. Van Eck Assoc Corp has 0% invested in Clean Harbors, Inc. (NYSE:CLH) for 10,916 shares. Hbk Invests LP holds 17,000 shares or 0.01% of its portfolio. Moreover, Glob X Ltd has 0% invested in Clean Harbors, Inc. (NYSE:CLH). Weaver C Barksdale & Associate Incorporated reported 270 shares or 0.02% of all its holdings. Cypress Cap Mngmt (Wy) invested in 195 shares. Thrivent Financial For Lutherans holds 0% or 11,120 shares in its portfolio. Manchester Mngmt Limited Co has 132 shares for 0% of their portfolio. Financial Bank Of America Corp De owns 350,761 shares for 0% of their portfolio. Green Square Ltd Liability Corporation owns 0.11% invested in Clean Harbors, Inc. (NYSE:CLH) for 11,220 shares.

Pivot Point Capital Partners Llc, which manages about $245.50 million and $125.50M US Long portfolio, upped its stake in Monro Muffler Brake Inc (NASDAQ:MNRO) by 133,100 shares to 356,700 shares, valued at $19.99M in 2017Q3, according to the filing.

Analysts await Clean Harbors, Inc. (NYSE:CLH) to report earnings on February, 28. They expect $0.06 earnings per share, up 200.00% or $0.12 from last year’s $-0.06 per share. CLH’s profit will be $3.42M for 233.33 P/E if the $0.06 EPS becomes a reality. After $0.21 actual earnings per share reported by Clean Harbors, Inc. for the previous quarter, Wall Street now forecasts -71.43% negative EPS growth.

Since August 24, 2017, it had 0 buys, and 3 insider sales for $313,845 activity. Weber Brian P sold 490 shares worth $27,528. Shares for $51,007 were sold by Dugas Eric J..

Among 14 analysts covering Clean Harbors Inc. (NYSE:CLH), 6 have Buy rating, 0 Sell and 8 Hold. Therefore 43% are positive. Clean Harbors Inc. had 38 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Needham with “Buy” on Thursday, November 5. The stock of Clean Harbors, Inc. (NYSE:CLH) earned “Hold” rating by Canaccord Genuity on Wednesday, August 9. The stock of Clean Harbors, Inc. (NYSE:CLH) earned “Market Perform” rating by Raymond James on Thursday, November 2. KeyBanc Capital Markets downgraded the shares of CLH in report on Thursday, August 3 to “Sector Weight” rating. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, October 5 report. The stock of Clean Harbors, Inc. (NYSE:CLH) has “Underperform” rating given on Tuesday, January 26 by Raymond James. The stock has “Neutral” rating by Sterne Agee CRT on Tuesday, March 22. The stock of Clean Harbors, Inc. (NYSE:CLH) earned “Hold” rating by Robert W. Baird on Thursday, September 7. The firm earned “Underweight” rating on Tuesday, January 10 by Barclays Capital. The company was initiated on Friday, August 26 by Macquarie Research.

Platinum Investment Management Ltd, which manages about $22.00 billion and $3.96B US Long portfolio, decreased its stake in Qiagen Nv by 24,451 shares to 1.11M shares, valued at $34.90 million in 2017Q3, according to the filing. It also reduced its holding in Alphabet Inc by 3,100 shares in the quarter, leaving it with 178,702 shares, and cut its stake in Carnival Corp (NYSE:CCL).

Investors sentiment decreased to 0.78 in 2017 Q3. Its down 0.52, from 1.3 in 2017Q2. It dropped, as 51 investors sold SGEN shares while 74 reduced holdings. 29 funds opened positions while 69 raised stakes. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. D E Shaw &, New York-based fund reported 177,519 shares. 5,200 are owned by Carl Domino. First Quadrant Limited Partnership Ca, California-based fund reported 1,000 shares. Baker Bros Advisors Ltd Partnership reported 20.18% stake. Macquarie Gp Limited stated it has 95,917 shares or 0.01% of all its holdings. Hall Laurie J Trustee owns 0.01% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 340 shares. Wisconsin-based Northwestern Mutual Wealth Mgmt has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). Manufacturers Life Insur Company The holds 0% in Seattle Genetics, Inc. (NASDAQ:SGEN) or 4,970 shares. Keybank Association Oh holds 0% or 6,935 shares. Zurcher Kantonalbank (Zurich Cantonalbank) owns 23,229 shares. Public Employees Retirement Sys Of Ohio holds 0.02% or 61,788 shares. Colorado-based Public Employees Retirement Association Of Colorado has invested 0.01% in Seattle Genetics, Inc. (NASDAQ:SGEN). Pioneer Fincl Bank N A Or, Oregon-based fund reported 10,000 shares. Pathstone Family Office Ltd Limited Liability Company reported 330 shares. Platinum Investment Mgmt Ltd owns 40,500 shares for 0.06% of their portfolio.

Since August 7, 2017, it had 0 buys, and 17 sales for $9.99 million activity. DOBMEIER ERIC had sold 5,343 shares worth $255,900. On Thursday, August 31 Cline Darren S sold $397,466 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) or 7,569 shares. The insider HIMES VAUGHN B sold $532,190. DRACHMAN JONATHAN G sold $475,414 worth of stock. $501,176 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) was sold by SIMPSON TODD E.

Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 7 have Buy rating, 0 Sell and 11 Hold. Therefore 39% are positive. Seattle Genetics had 56 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Outperform” rating by RBC Capital Markets given on Friday, July 31. The firm earned “Buy” rating on Friday, October 27 by H.C. Wainwright. The rating was maintained by Needham on Monday, October 23 with “Buy”. Piper Jaffray maintained the stock with “Hold” rating in Friday, October 27 report. The firm has “Overweight” rating given on Thursday, February 4 by Barclays Capital. Goldman Sachs initiated the stock with “Sell” rating in Wednesday, November 18 report. The firm has “Hold” rating by Cowen & Co given on Tuesday, June 6. The firm earned “Neutral” rating on Monday, October 30 by JP Morgan. RBC Capital Markets maintained Seattle Genetics, Inc. (NASDAQ:SGEN) on Monday, November 13 with “Buy” rating. SunTrust maintained Seattle Genetics, Inc. (NASDAQ:SGEN) on Tuesday, October 3 with “Hold” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts